Back to School: Children and COVID-19
As students return to in-person learning this year, schools continue to grapple with reducing the spread of COVID-19 and the evolving state of the pandemic. The recent surges in cases and hospitalizations among children and the Delta variant are particularly concerning for children under 12, who are not yet eligible for the COVID-19 vaccine. The ongoing health, economic, and social consequences of the pandemic continue to impact children.
- Cases and hospitalizations: Cases have jumped as the Delta variant spreads among unvaccinated populations and has led to a record high in children’s hospitalizations. Doctors predict COVID-19 cases will continue to rise among children and children’s hospitals are preparing for an uptick in multisystem inflammatory syndrome (MIS-C).
- Back to school: Across the country, students and teachers are quarantined for coronavirus exposure and some schools have already switched back to remote learning. While districts begin announcing vaccine mandates for teachers, some states are challenging mask mandates in schools.
- Vaccine: The Pfizer COVID-19 vaccine is expected to be available for children ages 5 to 11 in late fall or early winter. More parents are considering vaccinations as more children are infected by the Delta variant. Currently, over 50% of adolescents ages 12 to 15 have received at least one dose of the COVID-19 vaccine.